Valendo Health
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete:02 · 05
01 / WHAT IT BUILT
What the company did
Valendo Health is a Boston-based value-based care company built at startup creator Redesign Health, focused on endocrinology. It partners with endocrinology practices to improve diabetes care, providing technology — a telehealth platform, remote patient monitoring and data-aggregation tools — plus a telehealth-enabled care team of dietitians, nurse practitioners, on-call endocrinologists and diabetes educators, helping practices transition from fee-for-service to value-based care contracts.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Launch
Valendo Health launched with $4 million in seed funding as the first Redesign Health startup of the year, led by CEO and co-founder Dave Terry, with two initial provider partners: Cecelia Health and Advanced Metabolic Care & Research (AMCR) in Southern California.
- Provider partnerships
The company announced partnerships with endocrinology practices to improve access and outcomes for people with diabetes, using value-based care contracts that reward specialists for improving care and reducing costs rather than generating more visits.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.